Home/Filings/4/0000905148-25-004141
4//SEC Filing

Nguyen AnhCo 4

Accession 0000905148-25-004141

CIK 0001604464other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:55 PM ET

Size

6.4 KB

Accession

0000905148-25-004141

Insider Transaction Report

Form 4
Period: 2025-11-17
Nguyen AnhCo
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2025-11-17$13.19/sh2,859$37,69965,030 total
  • Sale

    Common Stock

    2025-11-17$13.19/sh56$73964,974 total
Footnotes (2)
  • [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001977970

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:55 PM ET
Size
6.4 KB